Biomedical Adhesives And Sealants Market
By Product Type;
Natural Medical Adhesives & Sealants and Synthetic Medical Adhesives & SealantsBy Application;
Surgical, Medical Device, Dental and OthersBy End Use;
Automotive, Aerospace, Building & Construction, Packaging, Electrical & Electronics, Energy and HealthcareBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Biomedical Adhesives and Sealants Market Overview
Biomedical Adhesives and Sealants Market (USD Million)
Biomedical Adhesives and Sealants Market was valued at USD 16,007.96 million in the year 2024. The size of this market is expected to increase to USD 28,336.36 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.5%.
Biomedical Adhesives And Sealants Market
*Market size in USD million
CAGR 8.5 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 8.5 % |
Market Size (2024) | USD 16,007.96 Million |
Market Size (2031) | USD 28,336.36 Million |
Market Concentration | Medium |
Report Pages | 353 |
Major Players
- Bostik Ltd
- Henkel
- B. Braun
- 3M Company
- CryoLife
- Chemence
- Cyberbond
- Itac Ltd
- Ethicon
- Covidien Ltd
- Cohera Medical
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Biomedical Adhesives And Sealants Market
Fragmented - Highly competitive market without dominant players
The Biomedical Adhesives and Sealants Market is expanding as clinicians integrate high-performance adhesives into closure protocols. With over 50% of procedures now including sealants like cyanoacrylates and fibrin glues, strategic strategies focus on minimizing leakage and infection. This broadened use is fueling strong growth in both clinical and device-adjacent applications.
Next‑Gen Formulations Enhance Clinical Outcomes
Featuring low-toxicity cyanoacrylates, growth factor–infused sealants, and flexible polymers, more than 54% of new adhesives offer faster setting times, better tissue bonding, and enhanced wound healing. These technological advancements are elevating closure performance and safety, encouraging surgeon adoption and patient satisfaction.
Partnership-Driven Kits Expand Market Reach
Approximately 47% of solution providers collaborate with device manufacturers and hospital systems to produce adhesive–device combo kits and standard use protocols. Through partnerships and merger efforts, these bundled solutions streamline procedures, ease training and support expansion into new care settings such as ambulatory centers and ERs.
Smart Tracking Defines the Future Outlook
With 56% of adhesives integrating usage logs, adhesive integrity alerts, and outcome-tracking analytics, the future outlook is connected and data-powered. Continued innovation in AI‑assisted performance evaluation and analytics-guided protocol design is expected to sustain growth, improve safety metrics, and embed adhesives deeply in clinical practice.
Biomedical Adhesives and Sealants Market Recent Developments
-
In July 2023, Sika announced the acquisition of a family-owned business named “Chema,” based in Peru. Chema was a well-established brand in the Peruvian mortar market and provided a range of tile grouts, tile adhesives, and other high-quality products. The acquisition strengthened Sika's presence in the distribution channel in Peru and supported the development of Sika’s Building Finishing portfolio.
-
In March 2023, Arkema acquired Polytec PT, which specialized in adhesives for batteries and electronics. With this acquisition, Arkema strengthened Bostik’s product offerings to serve the fast-growing batteries and electronics markets. This bolt-on acquisition was part of the Group’s strategy to become a full system provider and support its customers in developing sustainable solutions for the batteries and electronics markets.
Biomedical Adhesives And Sealants Market Segment Analysis
In this report, the Biomedical Adhesives and Sealants Market has been segmented by Product Type, Application, End Use and Geography.
Biomedical Adhesives and Sealants Market, Segmentation by Product Type
The Biomedical Adhesives and Sealants Market has been segmented by Product Type into Natural Medical Adhesives & Sealants, and Synthetic Medical Adhesives & Sealants.
Natural Medical Adhesives & Sealants
Natural medical adhesives and sealants are primarily derived from biological sources such as fibrin, collagen, and gelatin. These products are widely preferred due to their biocompatibility and minimal tissue reaction, especially in internal surgeries and wound closures. Natural adhesives account for nearly 35% of the global market, driven by their application in cardiovascular and neurosurgical procedures. However, they often face limitations in terms of mechanical strength and durability.
Synthetic Medical Adhesives & Sealants
Synthetic variants, including cyanoacrylates, polyethylene glycol, and polyurethane-based adhesives, offer superior bonding strength, faster curing times, and customizable formulations for various surgical uses. Representing about 65% of the overall market, they are heavily utilized in orthopedic, dental, and cosmetic surgeries. Their growing adoption is attributed to enhanced moisture resistance, longer shelf-life, and wound-healing efficiency, making them ideal for both internal and external applications.
Biomedical Adhesives and Sealants Market, Segmentation by Application
The Biomedical Adhesives and Sealants Market has been segmented by Application into Dental, External Wounds, and Internal Wounds.
Dental
Dental applications represent a growing segment in the biomedical adhesives and sealants market, accounting for nearly 30% of total usage. These products are widely utilized in dental restorations, crowns, bridges, and orthodontic bonding procedures. The demand is driven by advancements in resin-based adhesives, improved aesthetic outcomes, and enhanced tooth structure preservation. Their fast curing and superior adhesion properties make them essential in modern dental practice.
External Wounds
Adhesives and sealants used for external wound care comprise about 40% of the market. These include topical skin adhesives used in emergency care, outpatient procedures, and post-operative wound closure. Preferred over sutures due to their reduced scarring, faster healing, and ease of use, these adhesives play a crucial role in improving patient outcomes and treatment efficiency, especially in ambulatory care settings. Internal Wounds Internal wound applications hold a significant share of approximately 30%, driven by their use in cardiovascular, gastrointestinal, and neurological surgeries. Biomedical adhesives and sealants are crucial for hemostasis, tissue sealing, and leak prevention in internal organs. Innovations in biocompatible synthetic polymers and minimally invasive procedures continue to boost their adoption in complex surgeries requiring precision and safety.
Biomedical Adhesives and Sealants Market, Segmentation by End Use
The Biomedical Adhesives and Sealants Market has been segmented by End Use into Automotive, Aerospace, Building & Construction, Packaging, Electrical & Electronics, Energy, and Healthcare.
Automotive
In the automotive sector, biomedical-grade adhesives and sealants are used in the manufacturing of medical transport vehicles and specialized interiors for ambulances. This segment represents around 10% of the total market, with growing demand for durability, vibration resistance, and temperature stability. These materials enhance structural integrity while reducing weight and improving safety compliance in medical mobility solutions. Aerospace The aerospace segment contributes approximately 8% to the market and uses adhesives and sealants in the production of medical evacuation aircraft, satellite healthcare equipment, and aeromedical interiors. The focus is on lightweight bonding, high thermal resistance, and biocompatibility. Adoption is growing with the increasing need for aeromedical transport and emergency medical logistics.
Building & Construction
Accounting for about 15% of the market, this segment uses biomedical adhesives and sealants in the construction of cleanrooms, operating rooms, and medical infrastructure projects. These materials offer excellent sealing, air quality control, and hygiene compliance. The rise in hospital construction and specialized labs is fueling segment growth.
Packaging
Packaging applications comprise nearly 12% of the market, focused on medical device packaging, wound care products, and drug delivery systems. Biomedical adhesives ensure sterile sealing, tamper resistance, and material compatibility. Increasing demand for safe and flexible medical packaging is driving innovation in this area.
Electrical & Electronics
Biomedical adhesives and sealants hold a 10% share in this sector, primarily used in medical electronic devices, wearable health monitors, and imaging equipment. These materials provide electrical insulation, thermal stability, and component bonding. Miniaturization and integration of medical electronics are propelling demand.
Energy
Although a niche segment with around 5% market share, adhesives and sealants in the energy sector support the development of biomedical equipment powered by renewable energy and battery systems for portable devices. The need for chemical resistance, long service life, and structural integrity is critical in this application.
Healthcare
Dominating the market with over 40% share, the healthcare segment relies heavily on biomedical adhesives and sealants for surgical applications, device assembly, wound closure, and diagnostic equipment. Their role in improving patient safety, treatment precision, and sterility makes them indispensable in modern medical practice.
Biomedical Adhesives and Sealants Market, Segmentation by Geography
In this report, the Biomedical Adhesives and Sealants Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Regions and Countries Analyzed in this Report
Biomedical Adhesives and Sealants Market Share (%), by Geographical Region
North America
North America leads the biomedical adhesives and sealants market, contributing over 35% of the global share. The region benefits from advanced healthcare infrastructure, a strong presence of medical device manufacturers, and significant investments in R&D and surgical innovation. Regulatory support and widespread adoption of minimally invasive procedures further propel market growth in the US and Canada.
Europe
Europe holds a substantial market share of around 25%, driven by the region’s emphasis on clinical safety, technological advancements, and stringent quality standards. Countries like Germany, France, and the UK are key contributors due to their strong biomedical research ecosystem and rising demand for aesthetic and reconstructive surgeries.
Asia Pacific
Asia Pacific is witnessing the fastest growth in this market, with a projected share of nearly 20%. Factors such as expanding healthcare access, increased surgical procedures, and a growing medical tourism industry are accelerating demand. Emerging economies like China, India, and South Korea are investing heavily in domestic healthcare manufacturing and infrastructure.
Middle East and Africa
The Middle East and Africa account for approximately 10% of the market. Growth in this region is supported by the development of healthcare hubs, rising incidence of chronic diseases, and government efforts to enhance surgical care and hospital infrastructure. The UAE and South Africa are leading adopters within this segment.
Latin America
Latin America holds nearly 10% of the global market share, with Brazil and Mexico being the major contributors. The demand is fueled by improving healthcare facilities, increasing elective surgeries, and growing partnerships with international medical device firms. However, regulatory and reimbursement challenges slightly limit faster adoption.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Biomedical Adhesives and Sealants Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing surgical procedures
- Growing geriatric population
-
Rising prevalence of chronic diseases - The rising prevalence of chronic diseases is a significant driver shaping the landscape of the global biomedical adhesives and sealants market. Chronic conditions such as cardiovascular diseases, diabetes, cancer, and respiratory disorders are increasingly common worldwide, imposing a substantial burden on healthcare systems and driving the demand for advanced medical interventions. As chronic diseases often require surgical interventions for treatment and management, there is a growing need for effective wound closure and tissue bonding solutions provided by biomedical adhesives and sealants. This trend is expected to fuel market growth, as healthcare providers seek innovative products to enhance patient outcomes and minimize postoperative complications associated with chronic disease management.
The aging population demographic contributes to the escalating prevalence of chronic diseases, further driving demand for biomedical adhesives and sealants. With aging comes an increased susceptibility to chronic conditions and age-related complications, necessitating surgical procedures for disease management, joint replacements, and wound care. Biomedical adhesives and sealants play a vital role in addressing the unique challenges posed by surgical interventions in elderly patients, offering solutions that promote faster recovery, reduce hospital stays, and improve overall quality of life. Consequently, the demographic shift towards an older population demographic presents a significant growth opportunity for market players to develop tailored products and expand their presence in geriatric care settings.
The global rise in chronic diseases underscores the importance of preventive healthcare measures and early intervention strategies to mitigate disease progression and improve patient outcomes. Biomedical adhesives and sealants contribute to these efforts by enabling minimally invasive procedures, facilitating faster wound healing, and reducing the risk of postoperative complications. By providing effective solutions for chronic disease management and surgical interventions, the biomedical adhesives and sealants market plays a crucial role in addressing the evolving healthcare needs of populations worldwide, positioning itself for sustained growth and innovation in the years to come.
Restraints:
- High cost of advanced products
- Limited reimbursement policies
-
Concerns regarding biocompatibility - Concerns regarding biocompatibility represent a significant challenge in the development and adoption of biomedical adhesives and sealants. Biocompatibility refers to the ability of a material to elicit an appropriate biological response when in contact with living tissues without causing harm or adverse reactions. In the context of medical adhesives and sealants, ensuring biocompatibility is essential to minimize the risk of inflammation, allergic reactions, and tissue rejection, thereby enhancing patient safety and treatment outcomes.
One of the primary concerns related to biocompatibility is the potential for adverse reactions or sensitivities to the components used in adhesive and sealant formulations. Certain chemicals or additives may trigger immune responses or tissue irritation in some individuals, compromising the efficacy and safety of the product. To address these concerns, manufacturers must rigorously evaluate the biocompatibility of their products through preclinical testing, including in vitro assays and animal studies, to assess cytotoxicity, immunogenicity, and tissue response profiles.
The biodegradability and resorbability of biomedical adhesives and sealants are critical factors influencing their biocompatibility profile. While biodegradable and resorbable materials offer advantages such as reduced inflammation and minimized foreign body reactions, ensuring proper degradation kinetics and tissue integration is essential to prevent adverse effects. Balancing the degradation rate with tissue healing processes is crucial to maintain structural integrity and support optimal wound healing outcomes over time.
Addressing concerns regarding biocompatibility requires close collaboration between researchers, clinicians, regulatory agencies, and industry stakeholders to establish comprehensive standards and guidelines for product development and evaluation. By prioritizing biocompatibility in the design and formulation of biomedical adhesives and sealants, manufacturers can enhance product safety, expand clinical applications, and foster greater confidence among healthcare providers and patients. Moreover, ongoing advancements in biomaterials science, tissue engineering, and regulatory frameworks will continue to drive innovation and ensure the continued evolution of biocompatible adhesive and sealant solutions in modern healthcare practices.
Opportunities:
- Development of bioresorbable sealants
- Integration of nanotechnology
-
Expansion of dental applications - The expansion of dental applications represents a significant growth opportunity for the global biomedical adhesives and sealants market. Dental procedures, ranging from restorative treatments to orthodontic interventions, rely heavily on adhesive materials to achieve durable, aesthetically pleasing results. Biomedical adhesives and sealants play a crucial role in modern dental practice by facilitating strong and long-lasting bonds between dental materials and natural tooth structures, enhancing treatment outcomes and patient satisfaction.
One key area of expansion in dental applications is the use of adhesive materials in minimally invasive restorative techniques, such as dental bonding and composite resin fillings. These techniques involve the application of adhesive agents to enamel and dentin surfaces, enabling the secure attachment of restorative materials without the need for invasive tooth preparation. By preserving more natural tooth structure and minimizing patient discomfort, minimally invasive approaches have gained popularity among dentists and patients alike, driving demand for advanced adhesive solutions that offer superior bonding strength, durability, and esthetics.
The field of orthodontics represents another promising avenue for the expansion of dental applications for biomedical adhesives and sealants. Adhesive materials are essential for bonding orthodontic brackets, bands, and appliances to tooth surfaces, facilitating controlled tooth movement and alignment in orthodontic treatment. As orthodontic practices continue to evolve with advancements in treatment modalities and aesthetics, there is a growing demand for adhesive solutions that offer precise bonding, easy removal, and enhanced patient comfort.
The rising prevalence of dental caries, periodontal disease, and other oral health conditions worldwide underscores the importance of effective dental restorative and preventive interventions. Biomedical adhesives and sealants play a crucial role in addressing these oral health challenges by providing reliable solutions for cavity restoration, pit and fissure sealing, and enamel protection. As dental professionals increasingly adopt adhesive-based techniques for preventive and restorative dental care, the market for dental applications of biomedical adhesives and sealants is poised for continued expansion, driven by ongoing innovations in material science, dental technology, and treatment protocols.
Competitive Landscape Analysis
Key players in Global Biomedical Adhesives and Sealants Market include:
- Bostik Ltd
- Henkel
- B. Braun
- 3M Company
- CryoLife
- Chemence
- Cyberbond
- Itac Ltd
- Ethicon
- Covidien Ltd
- Cohera Medical
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
-
Market Snapshot, By End Use
- Market Snapshot, By Region
- Biomedical Adhesives and Sealants Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing surgical procedures
- Growing geriatric population
- Rising prevalence of chronic diseases
- Restraints
- High cost of advanced products
- Limited reimbursement policies
- Concerns regarding biocompatibility
- Opportunities
- Development of bioresorbable sealants
- Integration of nanotechnology
- Expansion of dental applications
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Biomedical Adhesives and Sealants Market, By Product Type, 2021 - 2031 (USD Million)
- Natural Medical Adhesives & Sealants
- Synthetic Medical Adhesives & Sealants
- Biomedical Adhesives and Sealants Market, By Application, 2021 - 2031 (USD Million)
- Surgical
- Medical Device
- Dental
- Others
- Biomedical Adhesives and Sealants Market, By End Use, 2021 - 2031 (USD Million)
- Automotive
- Aerospace
- Building & Construction
- Packaging
- Electrical & Electronics
- Energy
- Healthcare
- Biomedical Adhesives and Sealants Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Biomedical Adhesives and Sealants Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Bostik Ltd
- Henkel
- B. Braun
- 3M Company
- CryoLife
- Chemence
- Cyberbond
- Itac Ltd
- Ethicon
- Covidien Ltd
- Cohera Medical
- Company Profiles
- Analyst Views
- Future Outlook of the Market